Tempest Tx (TPST): Bagan tingkat prakiraan

Tempest Therapeutics bases its research centers in California, utilizing external CDMO contractors for molecule synthesis to minimize operational disruptions. The company's price evolution on the GURU.Markets platform is currently at 6.97. The business relies on the development of metabolic drugs targeting liver and intestinal tumors, which allows for the effective distribution of investment risks across various market segments.

Tempest Therapeutics Corp (TPST): Target konsensus saka 04.07.2022 nganti 22.10.2026

Rincian analitis perusahaan Tempest Tx (TPST)

Indikator analitis utama Tempest Therapeutics Corp (TPST):

Rega tempesttx.com|TPST - Bagan rega target|Biji pasar Tempest Tx

Analisis fundamental perusahaan:tempesttx.com (TPST)

Produk asli Tempest Tx

Professional selection of resilient assets is based on comparing actual price action with the average target prices set by leading investment houses. By analyzing the market consensus target for the stock, an investor assesses how quickly experts adapt to fundamental changes, which is critical for Tempest Therapeutics (TPST) due to the high cost of FDA certification and the protection of unique patents for anti-tumor molecules that eliminate pressure from generics.

Perusahaan pesaing

Rega prakiraan analis ONC|Bagan rega target Halozyme HALO|RVMD (Revolution Medicines Inc) - Bagan tingkat prakiraan|AAPG - Bagan rega target|Target median analis CG Oncology Therapeutics CGON|URGN (UroGen Pharma Ltd.) - Target konsensus|BCAX: Rega prakiraan analis|PSNL (Personalis) - Prakiraan konsensus analis|Target konsensus Erasca Inc (ERAS)|Prakiraan konsensus analis DCTH|Prakiraan konsensus analis Y-mAbs Corp (YMAB)|Bagan rega target Aura Biosciences, Inc. AURA|CADL: Prakiraan gabungan firma investasi|Accuray - Prakiraan konsensus analis|SELLAS Life Sciences (SLS) - Target konsensus|ACTU: Prakiraan konsensus analis|Rata-rata rega prakiraan Citius Oncology Inc (CTOR)|Bagan rega target TuHURA Biosciences Inc.|TARA: Konsensus nilai wajar|Target konsensus FATE (Fate Therapeutics)|WHWK (aadibio.com) - Konsensus nilai wajar|Prakiraan konsensus analis TCRX (TScan Therapeutics, Inc.)|CSBR - Target konsensus|XBIT: Target konsensus|CVM - Prakiraan konsensus analis|OS Therapies (OSTX) - Bagan rega target|Radiopharm Theranostics Ltd - Konsensus nilai wajar|ARTV (Artiva Biotherapeutics Inc.) - Prakiraan konsensus analis|Rata-rata rega prakiraan Adlai Nortye Limited ANL|Target konsensus VERU (Veru Inc.)|Rega prakiraan analis XLO|Prakiraan konsensus analis RENB (Renovaro)|Mural Oncology PLC (MURA) - Rata-rata rega prakiraan|KAPA - Bagan rega target|OnKure Therapeutics Inc (OKUR) - Target konsensus|w2.cytomed.sg (GDTC) - Bagan rega target|Bagan tingkat prakiraan CRIS (Curis)|APLM (Apollomics Inc.) - Prakiraan konsensus analis|Rata-rata rega prakiraan Tharimmune Inc THAR|Bagan rega target Advanced Biomed Inc (ADVB)|Target median analis Genprex Inc|Calidi Biotherapeutics, Inc. - Target konsensus|Rega prakiraan analis SBFM (Sunshine Biopharma Inc.)|XBIO: Target konsensus|Konsensus nilai wajar SLRX (Salarius Pharmaceuticals Inc)|PPBT (Purple Biotech Corp) - Target konsensus|AONC: Rega prakiraan analis|BGNE (BeiGene, Ltd.) - Prakiraan konsensus analis|CKPT: Konsensus nilai wajar|Prakiraan konsensus analis ELEV|ICAD - Rata-rata rega prakiraan|Bagan rega target Ikena Oncology IKNA|Konsensus nilai wajar NTBL|Viracta - Prakiraan konsensus analis|MOR - Prakiraan konsensus analis|NAYA Biosciences Inc. (NAYA) - Bagan rega target|Bagan tingkat prakiraan AAPGV (Ascentage Pharma Group International)